- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HTLV-1 HBZ activates mTOR signaling pathway via inhibition of GADD34 ; volume:8 ; number:1 ; day:6 ; month:6 ; year:2011 ; pages:1 ; date:12.2011
Retrovirology ; 8, Heft 1 (6.6.2011), 1, 12.2011
- Creator
-
Mukai, Risa
- Contributor
-
Ohshima, Takayuki
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-8-S1-A155
- URN
-
urn:nbn:de:1111-2016080719711
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mukai, Risa
- Ohshima, Takayuki
- SpringerLink (Online service)
Other Objects (12)
FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells
Celecoxib activates autophagy by inhibiting the mTOR signaling pathway and prevents apoptosis in nucleus pulposus cells
Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
APOBEC3G & HTLV-1: Inhibition without deamination
Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Brain-restricted mTOR inhibition with binary pharmacology
Nutritional and pharmacological modes of mTOR inhibition
The mTOR pathway in the antiphospholipid syndrome
mTOR inhibition in management of advanced breast cancer
FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells
Celecoxib activates autophagy by inhibiting the mTOR signaling pathway and prevents apoptosis in nucleus pulposus cells
Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
APOBEC3G & HTLV-1: Inhibition without deamination
Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Brain-restricted mTOR inhibition with binary pharmacology
Nutritional and pharmacological modes of mTOR inhibition
The mTOR pathway in the antiphospholipid syndrome
mTOR inhibition in management of advanced breast cancer
FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells
Celecoxib activates autophagy by inhibiting the mTOR signaling pathway and prevents apoptosis in nucleus pulposus cells
Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
APOBEC3G & HTLV-1: Inhibition without deamination
Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Brain-restricted mTOR inhibition with binary pharmacology
Nutritional and pharmacological modes of mTOR inhibition
The mTOR pathway in the antiphospholipid syndrome